Acuta Capital Partners, LLC 13F Holdings · Q2 2026
Acuta Capital Partners, LLC reported 23 securities worth $143.49M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: PRAX (19.32%), WHWK (14.96%), TNGX (8.52%). Among its top 25 positions this quarter: 5 new, 9 added, 6 trimmed, 2 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PRAX | PRAXIS PRECISION MEDICINES I | $27.7M | 19.32% | 82,796 | Trimmed |
| 2 | WHWK | WHITEHAWK THERAPEUTICS INC | $21.5M | 14.96% | 4.7M | Added |
| 3 | TNGX | TANGO THERAPEUTICS INC | $12.2M | 8.52% | 390,949 | Trimmed |
| 4 | STRO | SUTRO BIOPHARMA INC | $9.0M | 6.25% | 270,251 | Added |
| 5 | AVBP | ARRIVENT BIOPHARMA INC | $7.6M | 5.29% | 218,694 | New |
| 6 | FDMT | 4D MOLECULAR THERAPEUTICS INC | $6.8M | 4.71% | 507,801 | New |
| 7 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $6.5M | 4.54% | 92,745 | Trimmed |
| 8 | OCUL | OCULAR THERAPEUTIX INC | $5.2M | 3.64% | 532,481 | Trimmed |
| 9 | ERAS | ERASCA INC | $4.9M | 3.39% | 265,199 | Trimmed |
| 10 | SRZN | SURROZEN INC | $4.5M | 3.14% | 173,395 | Added |
| 11 | ARGX | ARGEN SE - ADR | $4.4M | 3.04% | 4,705 | Added |
| 12 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $4.2M | 2.93% | 215,652 | Added |
| 13 | DSGN | DESIGN THERAPEUTICS INC | $4.1M | 2.85% | 282,564 | Added |
| 14 | NERV | MINERVA NEUROSCIENCES | $3.9M | 2.74% | 709,500 | Hold |
| 15 | TSHA | TAYSHA GENE THERAPIES INC | $3.8M | 2.67% | 561,808 | Added |
| 16 | AVLN | AVALYN PHARMA INC | $3.8M | 2.64% | 115,000 | New |
| 17 | AVTX | AVALO THERAPEUTICS INC | $3.4M | 2.40% | 186,308 | Added |
| 18 | AMLX | AMYLYX PHARMACEUTICALS INC | $3.0M | 2.10% | 168,115 | Added |
| 19 | ARTV | ARTIVA BIOTHERAPEUTICS INC | $2.5M | 1.76% | 260,416 | New |
| 20 | CMPX | COMPASS THERAPEUTICS INC | $1.3M | 0.91% | 595,213 | Trimmed |
| 21 | UTHR | UNITED THERAPEUTICS CORP | $1.2M | 0.84% | 2,224 | Hold |
| 22 | CTNM | CONTINEUM THERAPEUTICS INC-A | $1.0M | 0.72% | 63,095 | New |
| 23 | LBRX | LB PHARMACEUTICALS INC | $938,566 | 0.65% | 28,919 | Hold |
| 24 | FDMT | 4D MOLECULAR THERAPEUTICS INC | $0 | 0.00% | 0 | Exited |
| 25 | IDYA | IDEAYA BIOSCIENCES INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR